| David L Sheeks, OTR | |
|
862 Wyndham Hills Dr, Lexington, KY 40514-1520 | |
| (859) 582-9009 | |
| Not Available |
| Full Name | David L Sheeks |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 862 Wyndham Hills Dr, Lexington, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104158708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | R0711 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David L Sheeks, OTR 862 Wyndham Hills Dr, Lexington, KY 40514-1520 Ph: (859) 582-9009 | David L Sheeks, OTR 862 Wyndham Hills Dr, Lexington, KY 40514-1520 Ph: (859) 582-9009 |
News Archive
Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.
A new weight-loss supplement tested by the University of Oklahoma Health and Exercise Science Department has the potential to burn as many calories as a 20-minute walk, according to Joel T. Cramer, assistant professor of exercise physiology.
Depomed, Inc. today announced that it has closed the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion. The NUCYNTA franchise includes: NUCYNTA ER (tapentadol) extended release tablets indicated for the management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN), severe enough to require daily, around-the-clock, long-term opioid treatment; NUCYNTA (tapentadol), an immediate release version of tapentadol, for management of moderate to severe acute pain in adults; and NUCYNTA (tapentadol) oral solution, an approved oral form of tapentadol that has not been launched.
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to numerous and sweeping restrictions in many countries, including the UK, limiting social and economic activity.
A draft policy from the FDA's counterfeit drug task force, concerns drugs marketed in the United States that do not have required FDA approval and emphasizes the regulatory actions and the use of new technologies for safeguarding the integrity of the U.S. drug supply.
› Verified 8 days ago
Joseph Freeman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 Monarch St, Suite 110, Lexington, KY 40513 Phone: 859-296-1696 Fax: 859-296-1676 | |
Matthew Baumann, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 330 Waller Ave Ste 275, Lexington, KY 40504 Phone: 859-447-8600 Fax: 859-447-8599 | |
Hannah Scott, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 993 Mason Headley Rd, Lexington, KY 40504 Phone: 859-554-8185 | |
Jason Elliott Thompson, OTR/L, MBA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2250 Leestown Rd, Lexington, KY 40511 Phone: 859-233-4511 | |
Ms. Linda Diane Richardson, O.T.R., C.H.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2189 Sallee Dr, Lexington, KY 40513 Phone: 859-523-6981 | |
Victoria Elridge, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2024 Willis Dr, Lexington, KY 40511 Phone: 502-744-8166 | |
Claire Duvall Muchow, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 113 Johnston Blvd, Lexington, KY 40503 Phone: 919-801-3426 |